Publisher Correction | Published:

Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapy

Nature Reviews Cancervolume 18page526 (2018) | Download Citation

Subjects

Nature Reviews Cancer (2018) https://doi.org/10.1038/s41568-018-0009-4 Published online 25 April 2018

In the online html version of this article, the affiliations for Jessica L. Pettigrew and John C. Bell were not correct. Jessica L. Pettigrew is at the Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada and John C. Bell is at the Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. This is correct in the print and PDF versions of the article and has been corrected in the html version.

Author information

Affiliations

  1. Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada

    • Kwame Twumasi-Boateng
    • , Y. Y. Eunice Kwok
    •  & Brad H. Nelson
  2. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    • Jessica L. Pettigrew
  3. Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

    • John C. Bell
  4. Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

    • John C. Bell
  5. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada

    • Brad H. Nelson
  6. Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada

    • Brad H. Nelson

Authors

  1. Search for Kwame Twumasi-Boateng in:

  2. Search for Jessica L. Pettigrew in:

  3. Search for Y. Y. Eunice Kwok in:

  4. Search for John C. Bell in:

  5. Search for Brad H. Nelson in:

Corresponding authors

Correspondence to John C. Bell or Brad H. Nelson.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41568-018-0019-2